KetaminevsPsilocybin
A dissociative anesthetic used in medicine compared with a classical psychedelic.
Safety Disclaimer
This comparison is for educational purposes only and does not constitute medical advice or a recommendation to use any substance. All substances discussed are controlled under federal law. Individual responses vary significantly. Always prioritize safety, start with the lowest possible dose, and consult a healthcare provider before considering any psychoactive substance.
Side-by-Side Comparison
Ketamine
Arylcyclohexylamine (dissociative anesthetic)
Psilocybin
Tryptamine (indole alkaloid)
Arylcyclohexylamine (dissociative anesthetic)
Tryptamine (indole alkaloid)
Varies by formulation, route, redosing, health, and other substances
4–6 hours
Route-dependent; medical observation requirements differ
20–60 minutes
Clinician-prescribed; routes and products are not interchangeable
0.1g–5g+ dried mushrooms
- Dissociation from body and environment
- Pain relief and anesthesia
- Altered sense of space and time
- Profound dissociation can include loss of mobility, communication, and hazard awareness
- Some patients experience rapid antidepressant effects in clinical studies
- Visual enhancement and geometric patterns
- Emotional openness and introspection
- Altered time perception
- Sense of connection and unity
- Potential ego dissolution at higher doses
- Addiction potential (unlike classical psychedelics)
- Bladder damage with chronic use
- Respiratory depression at high doses
- Aspiration risk (nausea + dissociation)
- Dangerous with alcohol, benzos, and opioids
- Psychological distress at high doses
- Contraindicated with lithium and tramadol
- SSRIs reduce effects
- Not recommended for psychosis-spectrum conditions
- Temporary increase in heart rate and blood pressure
Schedule III federally. Racemic ketamine is FDA-approved as an anesthetic and may be used off-label; Spravato has label-specific psychiatric indications and REMS requirements.
Decriminalized in DC under Initiative 81 (2020). Schedule I federally.
Spravato has FDA-approved psychiatric indications. Racemic ketamine is studied and used off-label in selected settings. Evidence, response, duration, availability, and legal requirements vary.
FDA Breakthrough Therapy designation for treatment-resistant depression. Major trials at Johns Hopkins, NYU, and Imperial College London for depression, PTSD, anxiety, and addiction.
Key Differences
1Mechanism and classification
Ketamine is a dissociative anesthetic that blocks NMDA glutamate receptors. Psilocybin is a classical psychedelic that activates serotonin 5-HT2A receptors. They produce fundamentally different states of consciousness — dissociation vs. psychedelic expansion.
2Legal accessibility
Racemic ketamine is FDA-approved as an anesthetic and is also prescribed off-label in some settings. Esketamine (Spravato) has FDA-approved psychiatric indications and REMS requirements. Psilocybin remains Schedule I federally and has no FDA-approved medical use.
3Addiction potential
Ketamine can cause tolerance, misuse, and dependence, particularly with frequent exposure. Psilocybin generally shows lower compulsive-use potential in available evidence, but no substance or pattern of use is risk-free.
4Physical risk profile
The substances have different physical risks. Ketamine can cause urinary injury with repeated exposure, sedation, respiratory depression, aspiration, and dangerous interactions with depressants. Psilocybin can also cause cardiovascular changes, injury, severe distress, and clinically important psychiatric or medication-related risks.
Similarities
- Clinical research reports antidepressant effects for some patients, with different evidence, timelines, products, and regulatory status
- Both can alter perception, cognition, emotion, and awareness, but through different pharmacology
- Both have been studied in depression research, with different evidence and regulatory status
- Clinical screening, preparation, setting, monitoring, and follow-up can affect risk and care quality
- Research examines downstream plasticity-related signaling for both, but mechanisms and clinical meaning remain under study
- Timing varies by product, route, protocol, person, and comparison substance
Which Is Right for You?
We don't make recommendations. Instead, consider these questions to guide your own research:
- Are you comparing regulated clinical options? Product approval, off-label practice, provider availability, and state law differ; verify current local requirements with a qualified clinician.
- Are you seeking a psychedelic experience (expanded perception) or a dissociative experience (disconnection from body/environment)?
- What medical, psychiatric, medication, dependence, and setting risks apply to you? A simple overall safety ranking cannot answer that.
- Are you looking for something you can access through the medical system, or are you comfortable navigating decriminalized spaces?
- Do you have any conditions that affect bladder health or kidney function? Ketamine carries unique risks here.
Learn More
This content is for educational purposes only and does not constitute medical advice. Paradise Farmers Market promotes harm reduction through accurate information.